Back

Vascular endothelial growth factor-C and mortality in patients with diabetes and suspected coronary artery disease: from the ANOX study

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Diabetes, adiposity and metabolic syndrome Diabetes and the Heart, Other ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Takashi Unoki

Saiseikai Kumamoto Hospital, Kumamoto (Japan)

8 More presentations in this session

Presentation thumbnail
Arrythmias and heart rate increase in the LEADER trial and relation to risk of cardiovascular events
Doctor M. Husain (Toronto, CA)
Abstract Slides
Presentation thumbnail
Cardiovascular outcomes associated with SGLT2 vs DPP4 inhibitors in type 2 diabetic patients with and without established cardiovascular diseases: a propensity score-matched study
Professor B. Yan (Hong Kong, CN)
Abstract Slides
Presentation thumbnail
The combined treatment with glucagon like peptide-1 analogues and sodium-glucose co-transporter 2 causes a greater improvement of arterial stiffness than each treatment alone in type 2 diabetes .
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides
Presentation thumbnail
Cardiovascular risk according to add-on therapy in patients with type 2 diabetes
Mr D. Aagaard (Copenhagen, DK)
Abstract
Presentation thumbnail
Lentiviral transfer of interleukin 4 gene to 3T3-L1 adipocytes prevents development of lipid-induced insulin resistance
Ms S. Michurina (Pavlovo, RU)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Diabetes, adiposity and metabolic syndrome

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources